Related Experiment Videos
[Etomidate in Intralipid. A solution for pain-free injection]
Der Anaesthesist
|October 1, 1983
Summary
A novel etomidate formulation using Intralipid, an oil emulsion, was evaluated. This new intravenous injection method eliminated injection pain, offering a potentially improved anesthetic option.
Area of Science:
- Anesthesiology
- Pharmacology
- Intravenous drug delivery systems
Context:
- Etomidate is a lipophilic anesthetic agent.
- Traditional formulations can cause injection site pain.
- Alternative drug delivery systems are needed for improved patient comfort.
Purpose:
- To evaluate a new etomidate solution in an oil emulsion (Intralipid) for intravenous injection.
- To compare the pain experienced during injection of etomidate/Intralipid versus etomidate in glycolic solution (Hypnomidate) and methohexitone (Brietal).
Summary:
- A new formulation of etomidate dissolved in Intralipid was studied as an intravenous induction agent.
- Comparison with etomidate in glycolic solution and methohexitone revealed no pain upon injection with the etomidate/Intralipid formulation.
- This suggests Intralipid is a non-irritating vehicle for etomidate.
Impact:
- The etomidate/Intralipid formulation offers a potentially painless method for intravenous anesthetic induction.
- This innovation may enhance patient experience and reduce procedural discomfort during anesthesia.
- Further research could explore the pharmacokinetic and pharmacodynamic profiles of this novel formulation.